Resmed (RSMDF) Stock Price, News & Analysis
Company Description
RSMDF has gained 47.5% over the past year. Shares last traded at $24.52.
For FY2026, Resmed reported revenue of $5.7B with net income of $1.5B and diluted earnings per share of $10.43. The company operates at a net profit margin of 26.9%.
This page collects what Stock Titan holds for RSMDF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Resmed (RSMDF) last closed at $24.52. Over the past 12 months, RSMDF has gained 47.5%.
RSMDF Rankings
Latest News
SEC Filings
Resmed has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 144, 1 Form 10-K. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RSMDF SEC filings →
Financial Highlights
Resmed generated $5.7B in revenue in FY2026, retaining a 61.1% gross margin, operating income reached $1.9B (33.4% operating margin), and net income was $1.5B, reflecting a 26.9% net profit margin. Diluted earnings per share stood at $10.43. The company generated $1.8B in operating cash flow. With a current ratio of 3.10, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Resmed (RSMDF) currently stands at 357.4 thousand shares, up 54.6% from the previous reporting period, representing 0.3% of the float. Since September 2025, short interest has decreased by 25.7%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Resmed (RSMDF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 3.7 to 1000.0 days.